CellSeed Of Japan Establishes French Subsidiary To Market Corneas
This article was originally published in PharmAsia News
Executive Summary
The Japanese bioventure CellSeed says it has set up a unit in France to serve the European market for the regenerative corneas it is developing. CellSeed, a spinoff of Tokyo Women's Medical University Hospital, has the corneas undergoing clinical trials in France. The products are to be used in transplants of cultured corneas. (Click here for more - a subscription may be required